3
Published 2011
Canadian Agency for Drugs and Technologies in Health
...Canadian jurisdictions (except Quebec) must make a decision on the provision of S/D plasma...

4
Published 2011
Canadian Agency for Drugs and Technologies in Health
...Canadian jurisdictions (except Quebec) must make a decision on the provision of S/D plasma...

5
Published 2018
Canadian Agency for Drugs and Technologies in Health
... affecting 1 in 100,000 to 200,000 live births in Europe (1 in 62,500 in Saguenay-Lac-St-Jean, Quebec...

6
Published 2018
Canadian Agency for Drugs and Technologies in Health
... affecting 1 in 100,000 to 200,000 live births in Europe (1 in 62,500 in Saguenay-Lac-St-Jean, Quebec...

7
Published 2018
CADTH

8
Published 2018
CADTH

9
Published 2018
Canadian Agency for Drugs and Technologies in Health
... health care system perspective (Quebec used as proxy). The manufacturer did not apply a discount rate...

10
Published 2018
Canadian Agency for Drugs and Technologies in Health

11
Published 2018
Canadian Agency for Drugs and Technologies in Health

12
Published 2018
Canadian Agency for Drugs and Technologies in Health
... in 1,846 live births) was observed in the Saguenay-Lac Saint-Jean region in Quebec. Without treatment...

13
Published 2018
Canadian Agency for Drugs and Technologies in Health
... in 1,846 live births) was observed in the Saguenay-Lac Saint-Jean region in Quebec. Without treatment...

14
by Murphy, Gaetanne
Published 2014
Canadian Agency for Drugs and Technologies in Health
... forward by the public drug plans in Canada (excluding Quebec), as described in the Therapeutic Review...

15
by Murphy, Gaetanne
Published 2014
Canadian Agency for Drugs and Technologies in Health
... forward by the public drug plans in Canada (excluding Quebec), as described in the Therapeutic Review...